No results for ‘’
Bacil Pharma Ltd
₹13.23
(5.00%)
Fri, 11 Sept 2026, 09:48 am
Health Technology
Pharmaceuticals: Major
24.5KBacil Pharma Ltd Price to Earnings Ratio
The Bacil Pharma Ltd Price to Earnings Ratio is a key financial metric used by investors to evaluate Bacil Pharma Ltd's valuation, profitability, and overall financial performance. Tracking the Bacil Pharma Ltd Price to Earnings Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Bacil Pharma Ltd (NSE: , BSE: 524516) is currently trading at ₹13.23, with a market capitalization of ₹18.08Cr. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Bacil Pharma Ltd Price to Earnings Ratio is essential for fundamental analysis.
Bacil Pharma Ltd Price to Earnings Ratio Current Value
The current Bacil Pharma Ltd Price to Earnings Ratio stands at 0.
The Bacil Pharma Ltd Price to Earnings Ratio remains stable, indicating consistent financial performance.
Bacil Pharma Ltd Price to Earnings Ratio Historical Trend
The Bacil Pharma Ltd Price to Earnings Ratio has shown the following historical trend:
The decline in Bacil Pharma Ltd Price to Earnings Ratio indicates improving financial efficiency or better earnings growth.
What Bacil Pharma Ltd Price to Earnings Ratio Indicates for Investors
The Bacil Pharma Ltd Price to Earnings Ratio plays a crucial role in understanding the company's financial health and valuation.
A higher P/E ratio indicates investors expect strong future earnings growth, while a lower ratio may signal undervaluation.
Bacil Pharma Ltd Price to Earnings Ratio Analysis Summary
The Bacil Pharma Ltd Price to Earnings Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Bacil Pharma Ltd Price to Earnings Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Bacil Pharma Ltd Price to Earnings Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.